Publications by authors named "Mahmut Avcı"
Article Synopsis
- Cytokine storm significantly contributes to deaths in COVID-19 patients, prompting research into therapies like recombinant interferon lambda 1 (IFN-λ1) to prevent severe cases.
- A recent study analyzed serum samples from 208 hospitalized COVID-19 patients, revealing that low levels of IFN-λ1 and high levels of IL-6 are linked to clinical severity, while increasing anti-S1 IgG antibodies indicate potential recovery.
- Monitoring levels of IFN-λ1, IL-6, and antibodies in severe cases, especially in intensive care, can improve treatment management and help identify patients ready for discharge.
